Moderna posts surprise quarterly profit as it eyes RSV vaccine approval

Moderna posts surprise quarterly profit as it eyes RSV vaccine approval

Source: 
Medical Marketing and Media
snippet: 


Moderna posted a surprise quarterly profit as the company continues to pivot from its COVID-19 vaccine success to developing treatments in other disease states.